Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing.
暂无分享,去创建一个
[1] R. Morrison. Differential Sensitivities of Chlamydia trachomatis Strains to Inhibitory Effects of Gamma Interferon , 2000, Infection and Immunity.
[2] S. West,et al. Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. , 2000, American journal of epidemiology.
[3] B. Munoz,et al. Incidence of trichiasis in a cohort of women with and without scarring. , 1999, International journal of epidemiology.
[4] T. Quinn,et al. Azithromycin in control of trachoma , 1999, The Lancet.
[5] S. Lindsay,et al. Effect of fly control on trachoma and diar rhoea , 1999, The Lancet.
[6] O. Laeyendecker,et al. Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.
[7] B. Munoz,et al. Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. , 1997, The Journal of infectious diseases.
[8] P. Simmonds,et al. Virus 'quasispecies': making a mountain out of a molehill? , 1997, The Journal of general virology.
[9] K. Millman,et al. Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. , 1997, The Journal of clinical investigation.
[10] S. West,et al. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma , 1996, Infection and immunity.
[11] B. Van Der Pol,et al. Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars , 1996, Infection and immunity.
[12] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[13] N. Nagelkerke,et al. The epidemiology of Chlamydia trachomatis within a sexually transmitted diseases core group. , 1996, The Journal of infectious diseases.
[14] N. Padian,et al. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. , 1995, The Journal of infectious diseases.
[15] W. Stamm,et al. Sequence conservation in the major outer membrane protein gene among Chlamydia trachomatis strains isolated from the upper and lower urogenital tract. , 1995, The Journal of infectious diseases.
[16] Martin A. Nowak,et al. Causes of HIV diversity , 1995, Nature.
[17] M. A. Pickett,et al. Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma. , 1995, The Journal of infectious diseases.
[18] D. Gendron,et al. Variation outside variable segments of the major outer membrane protein distinguishes trachoma from urogenital isolates of the same serovar of Chlamydia trachomatis. , 1995, Genitourinary medicine.
[19] B. Munoz,et al. Impact of face-washing on trachoma in Kongwa, Tanzania , 1995, The Lancet.
[20] G. Paradis,et al. Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B , 1994, Infection and immunity.
[21] R. Brunham,et al. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (omp1) gene. , 1994, The Journal of clinical investigation.
[22] M. A. Pickett,et al. Genotyping of Chlamydia trachomatis from a trachoma-endemic village in the Gambia by a nested polymerase chain reaction: identification of strain variants. , 1992, The Journal of infectious diseases.
[23] R. Stephens,et al. Comparison of the major outer membrane protein variant sequence regions of B/Ba isolates: a molecular epidemiologic approach to Chlamydia trachomatis infections. , 1992, The Journal of infectious diseases.
[24] B. Thomas,et al. Small numbers of Chlamydia trachomatis elementary bodies on slides detected by the polymerase chain reaction. , 1992, Journal of clinical pathology.
[25] H. Whittle,et al. A longitudinal study of trachoma in a Gambian village: implications concerning the pathogenesis of chlamydial infection , 1992, Epidemiology and Infection.
[26] H. Caldwell,et al. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein , 1992, The Journal of experimental medicine.
[27] B. Munoz,et al. The epidemiology of trachoma in central Tanzania. , 1991, International journal of epidemiology.
[28] B. Munoz,et al. Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay , 1991, The Lancet.
[29] R. Locksley,et al. A single peptide from the major outer membrane protein of Chlamydia trachomatis elicits T cell help for the production of antibodies to protective determinants. , 1991, Journal of immunology.
[30] R. Yolken,et al. Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay , 1990, Journal of clinical microbiology.
[31] H. Caldwell,et al. Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin , 1990, Infection and immunity.
[32] S. West,et al. Reliability of photographs for grading trachoma in field studies. , 1990, The British journal of ophthalmology.
[33] H. Caldwell,et al. Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars , 1989, Infection and immunity.
[34] Lloyd M. Smith,et al. Fluorescence detection in automated DNA sequence analysis , 1986, Nature.
[35] M. Nei,et al. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. , 1986, Molecular biology and evolution.
[36] H. Taylor,et al. Ocular models of chlamydial infection. , 1985, Reviews of infectious diseases.
[37] S. Wang,et al. Importance of reinfection in the pathogenesis of trachoma. , 1985, Reviews of infectious diseases.
[38] A. Herring,et al. Rapid diagnosis of rotavirus infection by direct detection of viral nucleic acid in silver-stained polyacrylamide gels , 1982, Journal of clinical microbiology.
[39] J. L. Raven,et al. Extraction of serum vitamin B12 for radio-isotopic and Lactobacillus leichmannii assay. , 1975, Journal of clinical pathology.
[40] J. Grayston,et al. Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. , 1967, American journal of ophthalmology.
[41] E. Alexander,et al. Trachoma vaccine studies in monkeys. , 1967, American journal of ophthalmology-glaucoma.
[42] W. Fitch,et al. Construction of phylogenetic trees. , 1967, Science.
[43] S. Harmer. Zoology at the British Association , 1905, Nature.
[44] B. Munoz,et al. Trachoma: the forgotten cause of blindness. , 1997, Epidemiologic reviews.
[45] B. Munoz,et al. Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. , 1996, American journal of epidemiology.
[46] J. Goudsmit. The role of viral diversity in HIV pathogenesis. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[47] H. Caldwell,et al. Immunogenicity of a synthetic oligopeptide corresponding to antigenically common T-helper and B-cell neutralizing epitopes of the major outer membrane protein of Chlamydia trachomatis. , 1993, Vaccine.
[48] C. Heiner,et al. Rapid and reliable fluorescent cycle sequencing of double-stranded templates. , 1992, DNA sequence : the journal of DNA sequencing and mapping.
[49] M. Ward,et al. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. , 1990, Scandinavian journal of infectious diseases. Supplementum.
[50] B. Munoz,et al. Water availability and trachoma. , 1989, Bulletin of the World Health Organization.
[51] S. West,et al. A simple system for the assessment of trachoma and its complications. , 1987, Bulletin of the World Health Organization.